BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Fatemeh Moosavi, Elisa Giovannetti, Luciano Saso, Omidreza Firuzi. HGF/MET pathway aberrations as diagnostic, prognostic, and predictive biomarkers in human cancersCritical Reviews in Clinical Laboratory Sciences 2019; 56(8): 533 doi: 10.1080/10408363.2019.1653821
2
Anna Li, Fei-Yu Niu, Jie-Fei Han, Na-Na Lou, Jin-Ji Yang, Xu-Chao Zhang, Qing Zhou, Zhi Xie, Jian Su, Ning Zhao, Ying Huang, Yi-Long Wu. Predictive and prognostic value of de novo MET expression in patients with advanced non-small-cell lung cancerLung Cancer 2015; 90(3): 375 doi: 10.1016/j.lungcan.2015.10.021
3
Ulrich H. Weidle, Fabian Birzele, Achim Krüger. Molecular targets and pathways involved in liver metastasis of colorectal cancerClinical & Experimental Metastasis 2015; 32(6): 623 doi: 10.1007/s10585-015-9732-3
4
Conor A. Bradley, Philip D. Dunne, Victoria Bingham, Stephen McQuaid, Hajrah Khawaja, Stephanie Craig, Jackie James, Wendy L. Moore, Darragh G. McArt, Mark Lawler, Sonali Dasgupta, Patrick G. Johnston, Sandra Van Schaeybroeck. Transcriptional upregulation of c-MET is associated with invasion and tumor budding in colorectal cancerOncotarget 2016; 7(48): 78932 doi: 10.18632/oncotarget.12933
5
Jung Han Kim, Hyeong Su Kim, Bum Jun Kim, Jin Lee, Hyun Joo Jang. Prognostic value of c-Met overexpression in pancreatic adenocarcinoma: a meta-analysisOncotarget 2017; 8(42): 73098 doi: 10.18632/oncotarget.20392
6
Melanie Gündert, Dominic Edelmann, Axel Benner, Lina Jansen, Min Jia, Viola Walter, Phillip Knebel, Esther Herpel, Jenny Chang-Claude, Michael Hoffmeister, Hermann Brenner, Barbara Burwinkel. Genome-wide DNA methylation analysis reveals a prognostic classifier for non-metastatic colorectal cancer (ProMCol classifier)Gut 2019; 68(1): 101 doi: 10.1136/gutjnl-2017-314711
7
Ling Lim, Chao-Chih Wu, Yun-Ting Hsu, Fang-Ju Sun, Chih-Long Chang. Clinical significance of c-Met and phospho-c-Met (Tyr1234/1235) in ovarian cancerTaiwanese Journal of Obstetrics and Gynecology 2019; 58(1): 105 doi: 10.1016/j.tjog.2018.11.020
8
Fuyan Hu, Qing Wang, Zhiyuan Yang, Zeng Zhang, Xiaoping Liu. Network-based identification of biomarkers for colon adenocarcinomaBMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-07157-w
9
Jung Han Kim, Bum Jun Kim, Hyeong Su Kim. Clinicopathological impacts of high c-Met expression in head and neck squamous cell carcinoma: a meta-analysis and reviewOncotarget 2017; 8(68): 113120 doi: 10.18632/oncotarget.21303
10
Victoria Bingham, Leanne McIlreavey, Christine Greene, Edwina O’Doherty, Rebecca Clarke, Stephanie Craig, Manuel Salto-Tellez, Stephen McQuaid, Claire Lewis, Jacqueline James. RNAscope in situ hybridization confirms mRNA integrity in formalin-fixed, paraffin-embedded cancer tissue samplesOncotarget 2017; 8(55): 93392 doi: 10.18632/oncotarget.21851
11
Kyle C. Cuneo, Ranjit K. Mehta, Himabindu Kurapati, Dafydd G. Thomas, Theodore S. Lawrence, Mukesh K. Nyati. Enhancing the Radiation Response in KRAS Mutant Colorectal Cancers Using the c-Met Inhibitor CrizotinibTranslational Oncology 2019; 12(2): 209 doi: 10.1016/j.tranon.2018.10.005
12
Conor A. Bradley, Manuel Salto-Tellez, Pierre Laurent-Puig, Alberto Bardelli, Christian Rolfo, Josep Tabernero, Hajrah A. Khawaja, Mark Lawler, Patrick G. Johnston, Sandra Van Schaeybroeck. Targeting c-MET in gastrointestinal tumours: rationale, opportunities and challengesNature Reviews Clinical Oncology 2017; 14(9): 562 doi: 10.1038/nrclinonc.2017.40
13
Seyed Mostafa Parizadeh, Reza Jafarzadeh‐Esfehani, Danial Fazilat‐Panah, Seyed Mahdi Hassanian, Soodabeh Shahidsales, Majid Khazaei, Seyed Mohammad Reza Parizadeh, Majid Ghayour‐Mobarhan, Gordon A. Ferns, Amir Avan. The potential therapeutic and prognostic impacts of the c‐MET/HGF signaling pathway in colorectal cancerIUBMB Life 2019;  doi: 10.1002/iub.2063
14
Sander P.J. Joosten, Marcel Spaargaren, Hans Clevers, Steven T. Pals. Hepatocyte growth factor/MET and CD44 in colorectal cancer: partners in tumorigenesis and therapy resistanceBiochimica et Biophysica Acta (BBA) - Reviews on Cancer 2020; : 188437 doi: 10.1016/j.bbcan.2020.188437
15
Jung Han Kim, Bum Jun Kim, Hyeong Su Kim. Clinicopathological impacts of high c-Met expression in renal cell carcinoma: a meta-analysis and reviewOncotarget 2017; 8(43): 75478 doi: 10.18632/oncotarget.20796
16
Pauline Roussille, Gaelle Tachon, Claire Villalva, Serge Milin, Eric Frouin, Julie Godet, Antoine Berger, Sheik Emambux, Christos Petropoulos, Michel Wager, Lucie Karayan-Tapon, David Tougeron. Pathological and Molecular Characteristics of Colorectal Cancer with Brain MetastasesCancers 2018; 10(12): 504 doi: 10.3390/cancers10120504
17
Lili Duan, Wanli Yang, Xiaoqian Wang, Wei Zhou, Yujie Zhang, Jinqiang Liu, Hongwei Zhang, Qingchuan Zhao, Liu Hong, Daiming Fan. Advances in prognostic markers for colorectal cancerExpert Review of Molecular Diagnostics 2019; 19(4): 313 doi: 10.1080/14737159.2019.1592679
18
Elmira Safaie Qamsari, Sepideh Safaei Ghaderi, Bahareh Zarei, Ruhollah Dorostkar, Salman Bagheri, Farhad Jadidi-Niaragh, Mohammad Hossein Somi, Mehdi Yousefi. The c-Met receptor: Implication for targeted therapies in colorectal cancerTumor Biology 2017; 39(5): 101042831769911 doi: 10.1177/1010428317699118
19
Vincenzo Sforza, Erika Martinelli, Fortunato Ciardiello, Valentina Gambardella, Stefania Napolitano, Giulia Martini, Carminia della Corte, Claudia Cardone, Marianna L Ferrara, Alfonso Reginelli, Giuseppina Liguori, Giulio Belli, Teresa Troiani. Mechanisms of resistance to anti-epidermal growth factor receptor inhibitors in metastatic colorectal cancerWorld Journal of Gastroenterology 2016; 22(28): 6345-6361 doi: 10.3748/wjg.v22.i28.6345
20
Jung Han Kim, Hyeong Su Kim, Bum Jun Kim. MET inhibitors in advanced non-small-cell lung cancer: a meta-analysis and reviewOncotarget 2017; 8(43): 75500 doi: 10.18632/oncotarget.20824
21
Helgi Birgisson, Kostas Tsimogiannis, Eva Freyhult, Masood Kamali-Moghaddam. Plasma Protein Profiling Reveal Osteoprotegerin as a Marker of Prognostic Impact for Colorectal CancerTranslational Oncology 2018; 11(4): 1034 doi: 10.1016/j.tranon.2018.05.012
22
Kshipra S. Karnik, Ishudeep Singh Narula, Aniket P. Sarkate, Pravin S. Wakte. Auto QSAR‐ A Fast Approach for Creation and Application of QSAR Models through AutomationChemistrySelect 2020; 5(19): 5756 doi: 10.1002/slct.202000744
23
Yi-Long Wu, Ross Andrew Soo, Giuseppe Locatelli, Uz Stammberger, Giorgio Scagliotti, Keunchil Park. Does c-Met remain a rational target for therapy in patients with EGFR TKI-resistant non-small cell lung cancer?Cancer Treatment Reviews 2017; 61: 70 doi: 10.1016/j.ctrv.2017.10.003
24
Sarah Wedden, Keith Miller, Ian M. Frayling, Teresa Thomas, Alina Chefani, Karolina Miller, Angela Hamblin, Jenny C. Taylor, Corrado D’Arrigo. Colorectal Cancer Stratification in the Routine Clinical PathwayApplied Immunohistochemistry & Molecular Morphology 2019; 27(6): e54 doi: 10.1097/PAI.0000000000000631
25
Mansoor Saleh, Philippe A. Cassier, Lauriane Eberst, Gurudatta Naik, Van K. Morris, Shubham Pant, Catherine Terret, Ling Gao, Amanda Long, Huzhang Mao, Samuel McNeely, Erin K. Wagner, Roberto M. Carlesi, Siqing Fu. Phase I Study of Ramucirumab Plus Merestinib in Previously Treated Metastatic Colorectal Cancer: Safety, Preliminary Efficacy, and Pharmacokinetic FindingsThe Oncologist 2020;  doi: 10.1634/theoncologist.2020-0520
26
Meng Zhang, Guichao Li, Xiangjie Sun, Shujuan Ni, Cong Tan, Midie Xu, Dan Huang, Fei Ren, Dawei Li, Ping Wei, Xiang Du. MET amplification, expression, and exon 14 mutations in colorectal adenocarcinomaHuman Pathology 2018; 77: 108 doi: 10.1016/j.humpath.2018.03.024
27
Nele Van Der Steen, Ingrid Garajova, Christian Rolfo, Andrea Cavazzoni, Elisa Giovannetti. Targeting Cell Survival Pathways to Enhance Response to Chemotherapy2019; : 25 doi: 10.1016/B978-0-12-813753-6.00002-0
28
Jung Han Kim, Hyeong Su Kim, Bum Jun Kim, Hyun Joo Jang, Jin Lee. Prognostic value of c-Met overexpression in hepatocellular carcinoma: a meta-analysis and reviewOncotarget 2017; 8(52): 90351 doi: 10.18632/oncotarget.20087
29
Michael A. Rogers, Verena Kalter, Gemma Marcias, Marc Zapatka, Sebastian Barbus, Peter Lichter. CITED4 gene silencing in colorectal cancer cells modulates adherens/tight junction gene expression and reduces cell proliferationJournal of Cancer Research and Clinical Oncology 2016; 142(1): 225 doi: 10.1007/s00432-015-2011-5
30
Jonas P. Koch, Daniel M. Aebersold, Yitzhak Zimmer, Michaela Medová. MET targeting: time for a rematchOncogene 2020; 39(14): 2845 doi: 10.1038/s41388-020-1193-8
31
Xue Zhang, Jing Zuo, Long Wang, Jing Han, Li Feng, Yudong Wang, Zhisong Fan. Identification of differentially expressed genes between mucinous adenocarcinoma and other adenocarcinoma of colorectal cancer using bioinformatics analysisJournal of International Medical Research 2020; 48(8): 030006052094903 doi: 10.1177/0300060520949036
32
Qing-Wen Zhang, Zi-Dan Ye, Chang Shen, Hong-Xia Tie, Lei Wang, Lei Shi. Synthesis of novel 6,7-dimethoxy-4-anilinoquinolines as potent c-Met inhibitorsJournal of Enzyme Inhibition and Medicinal Chemistry 2019; 34(1): 124 doi: 10.1080/14756366.2018.1533822
33
Bing Liu, Zheng‑Zhi Liu, Mei‑Ling Zhou, Jian‑Wei Lin, Xue‑Mei Chen, Zhu Li, Wen‑Bin Gao, Zhen‑Dong Yu, Tao Liu. Development of c‑MET‑specific chimeric antigen receptor‑engineered natural killer cells with cytotoxic effects on human liver cancer HepG2 cellsMolecular Medicine Reports 2019;  doi: 10.3892/mmr.2019.10529
34
Aiwu Ruth He, Roger B. Cohen, Crystal S. Denlinger, Ashwin Sama, Ariel Birnbaum, Jimmy Hwang, Takami Sato, Nancy Lewis, Michelle Mynderse, Michele Niland, Jennifer Giles, Johan Wallin, Brian Moser, Wei Zhang, Richard Walgren, Elizabeth R. Plimack. First‐in‐Human Phase I Study of Merestinib, an Oral Multikinase Inhibitor, in Patients with Advanced CancerThe Oncologist 2019; 24(9) doi: 10.1634/theoncologist.2018-0411